Online citations, reference lists, and bibliographies.
← Back to Search

Doxorubicin Loaded Large-pore Mesoporous Hydroxyapatite Coated Superparamagnetic Fe3O4 Nanoparticles For Cancer Treatment.

Negar Abbasi Aval, J. Pirayesh Islamian, Milad Hatamian, Mohammad Arabfirouzjaei, J. Javadpour, Mohammad-Reza Rashidi
Published 2016 · Medicine, Chemistry
Referenced 2 times by Citationsy Users

Cite This
Download PDF
Analyze on Scholarcy
Share
In the present study, a series of multifunctional drug delivery systems based on mesostructured hydroxyapatite coating and superparamagnetic nanoparticles with pH-responsive characters was prepared. The structure of each new synthesized nanoscale composite was fully characterized by XRD, FTIR, TEM, VSM and BET. The results showed a good ordered mesostructure having large pores, high pore volume, high surface area, and varied super paramagnetic properties. The mesoporous hydroxyapatite coated super paramagnetic Fe3O4 nanoparticles were applied as a drug delivery carrier loaded with doxorubicin (DOX) as a model drug. The storage/release properties of the developed nonocarriers in phosphate buffer saline (PBS) were studied in two certain pHs: pH=7.4 (the human blood pH) and pH=5.5 (pH of cancer cells). The large pores in the synthesized mesoporous acted as an excellent carrier for DOX molecules with a loading efficiency of ≈93% which is much higher than that of the conventional hydroxyapatite particles. When the pH of the release medium (PBS) was changed from 7.4 to 5.5, the drug release increased significantly from 10% of the adsorbed drug to about 70%. DOX-loaded mesostructure hydroxyapatite reduced the viability of SKBR3 and T47D cells by 54.7 and 57.3%, respectively, which were very similar to 56.8 and 60.4% reduction resulted from free DOX incubation. This new drug delivery system which benefits from both super paramagnetic properties and pH-responsive performances may serve as a suitable platform for developing new biocompatible drug carriers and could have a good potential use in targeted cancer therapy.
This paper references
10.1021/la302066e
Fabrication and characterization of dendrimer-functionalized mesoporous hydroxyapatite.
Nabakumar Pramanik (2012)
10.1016/j.actbio.2010.10.004
Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles.
N. Tran (2011)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
10.1016/j.addr.2011.03.008
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.
Challa S. S. R. Kumar (2011)
10.1016/j.yexmp.2008.12.004
Nanoparticle-based targeted drug delivery.
R. Singh (2009)
10.1016/J.JNONCRYSOL.2011.09.020
Fabrication of mesoporous hydroxycarbonate apatite for oral delivery of poorly water-soluble drug carvedilol
Qinfu Zhao (2012)
10.1002/adma.201101586
Bioceramics: from bone regeneration to cancer nanomedicine.
M. Vallet-Regí (2011)
10.1016/J.MICROMESO.2005.07.046
Triblock co-polymer templating synthesis of mesostructured hydroxyapatite
Yufeng Zhao (2005)
10.1016/j.actbio.2011.09.032
Intrinsic magnetism and hyperthermia in bioactive Fe-doped hydroxyapatite.
A. Tampieri (2012)
10.1016/j.ijpharm.2012.01.043
Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting.
X. Chen (2012)
10.4048/jbc.2013.16.2.164
Enhancing the Effects of Low Dose Doxorubicin Treatment by the Radiation in T47D and SKBR3 Breast Cancer Cells
Fahimeh Aghaee (2013)
10.1016/J.MICROMESO.2012.01.037
Hydrothermal fabrication of mesoporous carbonated hydroxyapatite microspheres for a drug delivery system
Y. Guo (2012)
10.1016/j.actbio.2009.09.017
A novel route in bone tissue engineering: magnetic biomimetic scaffolds.
N. Bock (2010)
10.1371/journal.pone.0022445
Acidic Environment Leads to ROS-Induced MAPK Signaling in Cancer Cells
A. Riemann (2011)
10.1007/s10853-013-7328-3
Synthesis of mesoporous hydroxyapatite nanoparticles using a template-free sonochemistry-assisted microwave method
Tong Liang (2013)
10.1002/ADEM.201080036
pH Tunable Fluorescent Calcium Phosphate Nanocomposite for Sensing and Controlled Drug Delivery
Shashwat S. Banerjee (2011)
10.1016/j.actbio.2009.12.014
Polymeric micelle-templated synthesis of hydroxyapatite hollow nanoparticles for a drug delivery system.
F. Ye (2010)
10.1016/j.phrs.2013.01.009
cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy.
J. Shen (2013)
10.1016/j.cis.2011.08.003
Capillary condensation of adsorbates in porous materials.
T. Horikawa (2011)
10.1021/la3000137
Adsorption of doxorubicin on poly(methyl methacrylate)-chitosan-heparin-coated activated carbon beads.
Jianjun Miao (2012)
Clinical hyperthermia and chemotherapy.
Storm Fk (1989)
10.1016/J.JMMM.2010.11.080
Synthesis and hyperthermia property of hydroxyapatite–ferrite hybrid particles by ultrasonic spray pyrolysis
Akihiro Inukai (2011)
10.1016/j.cellsig.2013.11.030
FOXP3 inhibits NF-κB activity and hence COX2 expression in gastric cancer cells.
Q. Hao (2014)
10.1016/J.BIOMATERIALS.2003.10.081
Hydroxyapatite particles as a controlled release carrier of protein.
T. Matsumoto (2004)
10.1016/J.JMMM.2005.01.064
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
10.1016/j.jcis.2010.05.046
Synthesis and characterization of porous shell-like nano hydroxyapatite using cetrimide as template.
P. Shanthi (2010)
10.1016/J.DRUDIS.2007.06.002
Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
S. Son (2007)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
10.1016/J.APSUSC.2011.06.161
Template-directed hydrothermal synthesis of hydroxyapatite as a drug delivery system for the poorly water-soluble drug carvedilol
Qinfu Zhao (2011)
10.1016/j.biomaterials.2010.11.028
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy.
Murali M Yallapu (2011)
10.1016/j.actbio.2012.09.023
In situ doxorubicin-CaP shell formation on amphiphilic gelatin-iron oxide core as a multifunctional drug delivery system with improved cytocompatibility, pH-responsive drug release and MR imaging.
W-M Li (2013)
10.1016/J.MICROMESO.2011.04.022
Large-pore mesoporous silica-coated magnetite core-shell nanocomposites and their relevance for biomedical applications
J. Rosenholm (2011)
10.1016/J.MICROMESO.2008.07.002
Ordered mesoporous materials for drug delivery
S. Wang (2009)
10.1016/j.addr.2010.07.009
Nanoparticle-based theranostic agents.
J. Xie (2010)
10.4155/TDE.11.72
Nanoparticle-mediated hyperthermia in cancer therapy.
D. Chatterjee (2011)
Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.
P. Vaupel (1989)
10.1007/BF03245856
Magnetic nanoparticles: Synthesis, stabilization, functionalization, characterization, and applications
M. Faraji (2010)
10.1016/J.MATCHEMPHYS.2014.07.024
Mesoporous hydroxyapatite: Preparation, drug adsorption, and release properties
L. Gu (2014)
10.1016/j.colsurfb.2010.11.006
Synthesis and characterization of enzyme-magnetic nanoparticle complexes: effect of size on activity and recovery.
Hee Joon Park (2011)
10.1016/J.MICROMESO.2008.09.024
Fabrication and characterization of hydroxycarbonate apatite with mesoporous structure
Y. Guo (2009)
10.1016/j.bmc.2009.02.043
Nanoparticles in cellular drug delivery.
A. H. Faraji (2009)
10.1016/J.JMMM.2012.02.060
Heat dissipation and magnetic properties of surface-coated Fe3O4 nanoparticles for biomedical applications
A. Tomitaka (2012)
10.1039/c1cc15190h
Magnetic mesoporous carbonated hydroxyapatite microspheres with hierarchical nanostructure for drug delivery systems.
Y. Guo (2011)
10.1007/BF02479039
Determination of specific surface by the BET method
G. Fagerlund (1973)
10.1016/S1672-6529(11)60105-4
Preparation of Mesoporous Nano-Hydroxyapatite Using a Surfactant Template Method for Protein Delivery
Xiaodong Wu (2012)
10.1016/J.COLSURFA.2012.03.017
Biofunctional mesoporous silica nanoparticles for magnetically oriented target and pH-responsive controlled release of ibuprofen
Rong Xing (2012)
10.1016/j.addr.2009.11.002
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
O. Veiseh (2010)
10.1016/J.MSEC.2006.05.018
Nanocrystalline calcium phosphate ceramics in biomedical engineering
S. Kalita (2007)
10.1016/j.addr.2009.03.007
Magnetic nanoparticles for theragnostics.
V. Shubayev (2009)
10.1016/j.actbio.2011.06.028
Multifunctional magnetic mesoporous bioactive glass scaffolds with a hierarchical pore structure.
C. Wu (2011)
10.1016/j.actbio.2010.03.017
Synthesis of high surface area mesostructured calcium phosphate particles.
Suxiu. Ng (2010)
10.1021/JA01145A126
(CONTRIBUTION FROM THE MULTIPLE FELLOWSHIP OF BAUGH AND SONS COMPANY, MELLOX INSTITUTE) The Determination of Pore Volume and Area Distributions in Porous Substances. I. Computations from Nitrogen Isotherms
E. P. Barrett (1951)
10.1016/j.biomaterials.2011.05.089
Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
You Ling (2011)
10.1371/journal.pone.0038710
Magnetic Hydroxyapatite Bone Substitutes to Enhance Tissue Regeneration: Evaluation In Vitro Using Osteoblast-Like Cells and In Vivo in a Bone Defect
S. Panseri (2012)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
10.1039/C3TB20365D
Hollow mesoporous hydroxyapatite nanoparticles (hmHANPs) with enhanced drug loading and pH-responsive release properties for intracellular drug delivery.
Y. Yang (2013)
10.1007/BF02708495
Fabrication and characterization of porous hydroxyapatite ocular implant followed by anin vivo study in dogs
B. Kundu (2004)
10.1016/j.cis.2011.04.003
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles.
S. Laurent (2011)



This paper is referenced by
10.1016/j.breast.2017.03.009
Targeted superparamagnetic nanoparticles coated with 2-deoxy-d-gloucose and doxorubicin more sensitize breast cancer cells to ionizing radiation.
J. Pirayesh Islamian (2017)
10.3390/cancers12030634
In Vivo and In Vitro Anticancer Activity of Doxorubicin-loaded DNA-AuNP Nanocarrier for the Ovarian Cancer Treatment
Chang-Seuk Lee (2020)
10.1039/C7NJ04706A
Covalent immobilization of doxorubicin in glycine functionalized hydroxyapatite nanoparticles for pH-responsive release
Gunjan Verma (2018)
10.1016/j.colsurfb.2017.11.034
Facile one-pot fabrication of calcium phosphate-based composite nanoparticles as delivery and MRI contrast agents for macrophages.
M. Nakamura (2018)
10.2147/IJN.S147355
Magnetic hydroxyapatite: a promising multifunctional platform for nanomedicine application
S. Mondal (2017)
10.3390/APP7010060
Biodegradable and Biocompatible Systems Based on Hydroxyapatite Nanoparticles
P. Turon (2017)
10.1016/j.heliyon.2020.e04928
One-pot hydrothermal synthesis of a magnetic hydroxyapatite nanocomposite for MR imaging and pH-Sensitive drug delivery applications
Mehraneh Kermanian (2020)
10.3389/fbioe.2019.00168
3D Microfluidic Bone Tumor Microenvironment Comprised of Hydroxyapatite/Fibrin Composite
Jungho Ahn (2019)
10.1016/J.MSEC.2019.03.066
Mesoporous superparamagnetic hydroxyapatite nanocomposite: A multifunctional platform for synergistic targeted chemo-magnetotherapy.
Azadeh Izadi (2019)
10.1016/j.matchemphys.2019.122337
Catechin adsorption on magnetic hydroxyapatite nanoparticles: A synergistic interaction with calcium ions
Ahm Yusoff (2020)
10.1016/j.jconrel.2019.11.016
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market.
M. Gonçalves (2019)
10.1149/2.0501805JES
Electrochemical Deposition of Cisplatin on Pure Magnesium
Yu-Linag Lai (2018)
10.3390/antibiotics7020046
Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity
L. S. Arias (2018)
10.1007/s10904-019-01255-4
Apatite Coating of Iron Oxide Nanoparticles by Alternate Addition of Calcium and Phosphate Solutions: A Calcium and Carboxylate (Ca-COO) Complex-Mediated Apatite Deposition
Vincent Irawan (2019)
Synthesis and drug delivery applications for
Ping Zhao (2018)
10.1002/wnan.1504
Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite.
S. Mondal (2018)
10.1016/J.MSEC.2019.109953
Doxorubicin - chitosan - hydroxyapatite composite coatings on titanium alloy for localized cancer therapy.
Yu-Liang Lai (2019)
10.1007/s42114-020-00154-4
Bio-evaluation of doxorubicin (DOX)-incorporated hydroxyapatite (HAp)-chitosan (CS) nanocomposite triggered on osteosarcoma cells
Saikat Ghosh (2020)
10.1016/J.JDDST.2020.101576
Metal-based nanoparticles as radio-sensitizer in gastric cancer therapy
Sepehr Batooei (2020)
10.1016/J.RINP.2018.09.036
Synthesis and characterization of biomass CQDs doped WO2.72
Limin Dong (2018)
10.1080/21691401.2019.1645155
Cisplatin-functionalized three-dimensional magnetic SBA-16 for treating breast cancer cells (MCF-7)
M. Alomari (2019)
10.2147/IJN.S127528
Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy
Jieqiong Zhan (2017)
10.5603/NMR.a2018.0008
A study on drug delivery tracing with radiolabeled mesoporous hydroxyapatite nanoparticles conjugated with 2DG/DOX for breast tumor cells.
Mahdiyeh Shamsi (2018)
10.1039/c6cs00746e
Calcium-based biomaterials for diagnosis, treatment, and theranostics.
Chao Qi (2018)
Semantic Scholar Logo Some data provided by SemanticScholar